PT3555048T - Novos derivados de ácidos picolínicos e uso dos mesmos como intermediários - Google Patents
Novos derivados de ácidos picolínicos e uso dos mesmos como intermediáriosInfo
- Publication number
- PT3555048T PT3555048T PT178265740T PT17826574T PT3555048T PT 3555048 T PT3555048 T PT 3555048T PT 178265740 T PT178265740 T PT 178265740T PT 17826574 T PT17826574 T PT 17826574T PT 3555048 T PT3555048 T PT 3555048T
- Authority
- PT
- Portugal
- Prior art keywords
- intermediates
- acid derivatives
- picolinic acid
- new
- new picolinic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662436222P | 2016-12-19 | 2016-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3555048T true PT3555048T (pt) | 2021-09-29 |
Family
ID=60953912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT178265740T PT3555048T (pt) | 2016-12-19 | 2017-12-18 | Novos derivados de ácidos picolínicos e uso dos mesmos como intermediários |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10633341B2 (pt) |
| EP (1) | EP3555048B1 (pt) |
| JP (1) | JP7063902B2 (pt) |
| KR (1) | KR102454635B1 (pt) |
| CN (1) | CN110072851B (pt) |
| AU (1) | AU2017381739B2 (pt) |
| CA (1) | CA3044366A1 (pt) |
| DK (1) | DK3555048T3 (pt) |
| ES (1) | ES2891527T3 (pt) |
| HU (1) | HUE055764T2 (pt) |
| IL (1) | IL267042B (pt) |
| PL (1) | PL3555048T3 (pt) |
| PT (1) | PT3555048T (pt) |
| RU (1) | RU2769693C2 (pt) |
| SI (1) | SI3555048T1 (pt) |
| WO (1) | WO2018116139A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3999063A1 (en) | 2019-07-15 | 2022-05-25 | Novartis AG | Formulations of (s)-3-amino-6-methoxy-n-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-5-(trifluoromethyl)picolinamide |
| WO2023109939A1 (zh) * | 2021-12-17 | 2023-06-22 | 苏州晶云药物科技股份有限公司 | 吡啶类衍生物的晶型及其制备方法 |
| CN115073366A (zh) * | 2022-06-08 | 2022-09-20 | 都创(重庆)医药科技有限公司 | 一种基于微通道技术快速制备3-氯吡啶-2-甲酸的方法 |
| CN116396213A (zh) * | 2023-04-14 | 2023-07-07 | 济南大学 | 一种2-吡啶甲酸甲酯的制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998012179A1 (de) | 1996-09-18 | 1998-03-26 | Basf Aktiengesellschaft | Pyridinderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von tierischen schädlingen und schadpilzen |
| KR20000053201A (ko) | 1996-11-12 | 2000-08-25 | 한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 | 제초제로서 유용한 피라졸 유도체 |
| EP1582524B1 (en) | 2004-04-02 | 2008-08-13 | Ludwig Maximilians Universität | Method of preparing organomagnesium compounds |
| EP1810974A1 (en) | 2006-01-18 | 2007-07-25 | Ludwig-Maximilians-Universität München | Preparation and use of magnesium amides |
| PL2089364T3 (pl) * | 2006-11-08 | 2013-11-29 | Bristol Myers Squibb Co | Związki pirydynonu |
| US8461343B2 (en) | 2007-03-27 | 2013-06-11 | Sloan-Kettering Institute For Cancer Research | Synthesis of thiohydantoins |
| DE102007022490A1 (de) | 2007-05-14 | 2008-11-20 | Ludwig-Maximilians-Universität | Bisamid-Zinkbasen |
| US8247436B2 (en) * | 2010-03-19 | 2012-08-21 | Novartis Ag | Pyridine and pyrazine derivative for the treatment of CF |
| MX2013000391A (es) * | 2010-07-12 | 2013-03-08 | Hoffmann La Roche | 1-hidroxiimino-3-fenil-propanos. |
| ES2558457T3 (es) | 2011-09-16 | 2016-02-04 | Novartis Ag | Compuestos heterocíclicos para el tratamiento de fibrosis quística |
| WO2013038373A1 (en) | 2011-09-16 | 2013-03-21 | Novartis Ag | Pyridine amide derivatives |
| WO2013038378A1 (en) | 2011-09-16 | 2013-03-21 | Novartis Ag | Pyridine amide derivatives |
| CN103987699A (zh) * | 2011-10-21 | 2014-08-13 | 诺华股份有限公司 | 作为pi3k调节剂的喹唑啉衍生物 |
| PT3153511T (pt) | 2014-06-06 | 2019-06-28 | Astellas Pharma Inc | Derivado de 2-acilaminotiazole para utilização na prevenção ou tratamento de doenças da bexiga/trato urinário |
| US10544120B2 (en) | 2015-10-01 | 2020-01-28 | Bristol-Myers Squibb Company | Biaryl kinase inhibitors |
| RU2760733C2 (ru) | 2016-03-25 | 2021-11-30 | Эфферент Фармасьютикалз Инк. | Пиримидины и их варианты, и их применение |
-
2017
- 2017-12-18 DK DK17826574.0T patent/DK3555048T3/da active
- 2017-12-18 ES ES17826574T patent/ES2891527T3/es active Active
- 2017-12-18 PL PL17826574T patent/PL3555048T3/pl unknown
- 2017-12-18 AU AU2017381739A patent/AU2017381739B2/en active Active
- 2017-12-18 CA CA3044366A patent/CA3044366A1/en active Pending
- 2017-12-18 RU RU2019122609A patent/RU2769693C2/ru active
- 2017-12-18 EP EP17826574.0A patent/EP3555048B1/en active Active
- 2017-12-18 SI SI201730932T patent/SI3555048T1/sl unknown
- 2017-12-18 PT PT178265740T patent/PT3555048T/pt unknown
- 2017-12-18 WO PCT/IB2017/058081 patent/WO2018116139A1/en unknown
- 2017-12-18 KR KR1020197017408A patent/KR102454635B1/ko active IP Right Grant
- 2017-12-18 CN CN201780076811.1A patent/CN110072851B/zh active Active
- 2017-12-18 HU HUE17826574A patent/HUE055764T2/hu unknown
- 2017-12-18 JP JP2019533109A patent/JP7063902B2/ja active Active
- 2017-12-18 US US16/470,778 patent/US10633341B2/en active Active
-
2019
- 2019-06-02 IL IL267042A patent/IL267042B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3555048A1 (en) | 2019-10-23 |
| IL267042A (en) | 2019-07-31 |
| WO2018116139A1 (en) | 2018-06-28 |
| ES2891527T3 (es) | 2022-01-28 |
| RU2019122609A3 (pt) | 2021-02-19 |
| AU2017381739A1 (en) | 2019-05-30 |
| KR20190091460A (ko) | 2019-08-06 |
| JP7063902B2 (ja) | 2022-05-09 |
| EP3555048B1 (en) | 2021-07-07 |
| RU2769693C2 (ru) | 2022-04-05 |
| US10633341B2 (en) | 2020-04-28 |
| CA3044366A1 (en) | 2018-06-28 |
| US20190345107A1 (en) | 2019-11-14 |
| AU2017381739B2 (en) | 2020-06-11 |
| PL3555048T3 (pl) | 2021-12-06 |
| HUE055764T2 (hu) | 2021-12-28 |
| SI3555048T1 (sl) | 2021-11-30 |
| DK3555048T3 (da) | 2021-10-11 |
| RU2019122609A (ru) | 2021-01-19 |
| JP2020502194A (ja) | 2020-01-23 |
| IL267042B (en) | 2021-12-01 |
| CN110072851B (zh) | 2023-06-06 |
| CN110072851A (zh) | 2019-07-30 |
| KR102454635B1 (ko) | 2022-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1254057A1 (zh) | 用於製備膽汁酸衍生物的方法和中間體 | |
| IL241601B (en) | Derivatives of 4-amino-3-chloro-5-fluoro-6-(7-fluoro-h1-indol-6-yl)picolinic acids and their use as herbicides | |
| HK1253581A1 (zh) | 經取代的吡啶及使用方法 | |
| HRP20190432T1 (hr) | Spojevi pladienolid piridina i postupci uporabe | |
| HK1254055A1 (zh) | 製備奧貝膽酸及其衍生物的方法 | |
| IL267042B (en) | New picolinic acid histories and their use as intermediates | |
| IL255054A0 (en) | Tetrahydronephthyridinyl propionic acid derivatives and their uses | |
| HK1254367A1 (zh) | 新的工藝和中間體 | |
| EP3107540A4 (en) | Polymorphs of lomitapide and its salts | |
| HK1247196A1 (zh) | Scy-078的新型鹽及多晶型物 | |
| DK3200779T3 (en) | Novel anthranilic acid derivatives | |
| EP3263133B8 (en) | Pyridinone compound and use thereof | |
| IL249519A0 (en) | History of abscisic acid - mutated in the 3' position | |
| EP3337479A4 (en) | NOVEL POLYMORPH OF DOLUTEGRAVIR AND SALTS FROM IT | |
| HUE050178T2 (hu) | Piridinon vegyület és alkalmazása | |
| HUE048323T2 (hu) | Szubsztituált pirazolil-pirazol származék és annak alkalmazása gyomirtóként | |
| GB201513318D0 (en) | Novel compounds and their use |